CLASTOBAN 800 mg drug available again

At the end of May 2019, the BioProjet Laboratory announced to us that, in all city pharmacies, CLASTOBAN 800 mg, soluble, is available again, although it had been out of production since December 2017.

Very good news for all patients undergoing PENTOCLO treatment, in particular for those with ENT pathologies (osteoradionecrosis), and therefore difficulty swallowing.


The minutes of the ARSER general meeting of May 25, 2019 are available. If you have not received it, do not hesitate to request it by writing to: